Evidence map›Paper›PMID 23775568›Full record

ArticleHepatology (Baltimore, Md.)2014

Paracrine signals from liver sinusoidal endothelium regulate hepatitis C virus replication.

Ian A Rowe, Sukhdeep K Galsinh, Garrick K Wilson, Richard Parker, Sarah Durant, Catalin Lazar, Norica Branza-Nichita, Roy Bicknell, David H Adams, Peter Balfe and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Hepatitis B Virus Targets Lipid Transport Pathways to Infect Hepatocytes.Cellular and molecular gastroenterology and hepatology · 2023
    Article
  6. Role of liver sinusoidal endothelial cells in liver diseases.Nature reviews. Gastroenterology & hepatology · 2021
    Review
  7. Gene signatures of SARS-CoV/SARS-CoV-2-infected ferret lungs in short- and long-term models.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2020
    Article
  8. Review
  9. Article
  10. Review
  11. Liver sinusoidal endothelial cells - gatekeepers of hepatic immunity.Nature reviews. Gastroenterology & hepatology · 2018
    Review
  12. Article
  13. BMP Signalling at the Crossroad of Liver Fibrosis and Regeneration.International journal of molecular sciences · 2017
    Review
  14. [Liver sinusoidal endothelial cells regulate adaptive immune tolerance in the liver].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2017
    Review
  15. Review
  16. Effect of scavenger receptor class B type I antagonist ITX5061 in patients with hepatitis C virus infection undergoing liver transplantation.Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · 2016
    Article
  17. Angiogenesis and liver fibrosis.World journal of hepatology · 2015
    Review
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Ian A RoweHepatitis C Virus Research Group, Institute for Biomedical Research, University of Birmingham, Birmingham, UK; Centre for Liver Research and NIHR Birmingham Liver Biomedical Research Unit, Institute for Biomedical Research, University of Birmingham, Birmingham, UK.
Sukhdeep K Galsinh
Garrick K Wilson
Richard Parker
Sarah Durant
Catalin Lazar
Norica Branza-Nichita
Roy Bicknell
David H Adams
Peter Balfe
Jane A McKeating
University of Birmingham · GBInstitute of Biochemistry · RONIHR Birmingham Liver Biomedical Research Unit · GB

Funding

Medical Research Council G0300101Medical Research Council G0400496Medical Research Council G0700301Medical Research Council G0800476Medical Research Council G0801976Medical Research Council G1100247Medical Research Council G1100448Medical Research Council G9818340Wellcome Trust
6 · The paper itself

Abstract

unlabelledHepatitis C virus (HCV) is a major cause of global morbidity, causing chronic liver injury that can progress to cirrhosis and hepatocellular carcinoma. The liver is a large and complex organ containing multiple cell types, including hepatocytes, sinusoidal endothelial cells (LSEC), Kupffer cells, and biliary epithelial cells. Hepatocytes are the major reservoir supporting HCV replication; however, the role of nonparenchymal cells in the viral lifecycle remains largely unexplored. LSEC secrete factors that promote HCV infection and transcript analysis identified bone morphogenetic protein 4 (BMP4) as a candidate endothelial-expressed proviral molecule. Recombinant BMP4 increased HCV replication and neutralization of BMP4 abrogated the proviral activity of LSEC-conditioned media. Importantly, BMP4 expression was negatively regulated by vascular endothelial growth factor A (VEGF-A) by way of a VEGF receptor-2 (VEGFR-2) primed activation of p38 MAPK. Consistent with our in vitro observations, we demonstrate that in normal liver VEGFR-2 is activated and BMP4 expression is suppressed. In contrast, in chronic liver disease including HCV infection where there is marked endothelial cell proliferation, we observed reduced endothelial cell VEGFR-2 activation and a concomitant increase in BMP4 expression.

conclusionThese studies identify a role for LSEC and BMP4 in HCV infection and highlight BMP4 as a new therapeutic target for treating individuals with liver disease.

Indexed as

Bone Morphogenetic Protein 4Cell ProliferationCells, CulturedEndothelial CellsHepacivirusHepatocytesHumansIn Vitro TechniquesLiverp38 Mitogen-Activated Protein KinasesParacrine CommunicationVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2Virus ReplicationBMP4 protein, humanBone Morphogenetic Protein 4p38 Mitogen-Activated Protein KinasesVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2

Identifiers

PMID23775568
PMCPMC3992845
OpenAlexW2117866639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.